CKD患者晚期结直肠肿瘤的相关因素
本研究为前瞻性队列研究,纳入1706例CKD 3-5期(含透析或移植)患者,采用粪便免疫化学检测筛查结直肠肿瘤。多变量logistic回归显示,年龄较大、男性、使用硫唑嘌呤和促红细胞生成素与晚期结直肠肿瘤显著相关。
要点
- CKD患者晚期结直肠肿瘤检出率为6.9%。
- 年龄每增加1岁,OR为1.05。
- 男性、硫唑嘌呤使用和促红细胞生成素使用与风险升高相关。
核心结论
- 年龄较大、男性、使用促红细胞生成素和硫唑嘌呤与CKD患者晚期结直肠肿瘤显著相关。
研究设计与样本
- 前瞻性队列研究,纳入1706例CKD 3-5期患者,包括791例未接受肾脏替代治疗、418例透析和497例肾移植受者。
主要发现
- 117例(6.9%)检出晚期结直肠肿瘤,包括9例结直肠癌。
- 年龄较大OR为1.05(95%CI 1.03-1.07,P<0.001)。
- 男性OR为2.27(95%CI 1.45-3.54,P<0.001)。
- 硫唑嘌呤使用OR为2.99(95%CI 1.40-6.37,P=0.005)。
- 促红细胞生成素使用OR为1.92(95%CI 1.22-3.03,P=0.005)。
临床怎么用
- 对CKD患者,尤其老年男性、使用硫唑嘌呤或促红细胞生成素者,应考虑结直肠肿瘤筛查。
局限性
- 存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The risk of developing colorectal cancer in patients with chronic kidney disease (CKD) is twice that of the general population, but the factors associated with colorectal cancer are poorly understood. The aim of this study was to identify factors associated with advanced colorectal neoplasia in patients with CKD. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: Patients with CKD stages 3-5, including those treated with maintenance dialysis or transplantation across 11 sites in Australia, New Zealand, Canada, and Spain, were screened for colorectal neoplasia using a fecal immunochemical test (FIT) as part of the Detecting Bowel Cancer in CKD (DETECT) Study. EXPOSURE: Baseline characteristics for patients at the time of study enrollment were ascertained, including duration of CKD, comorbidities, and medications. OUTCOME: Advanced colorectal neoplasia was identified through a 2-step verification process with colonoscopy following positive FIT and 2-year clinical follow-up for all patients. ANALYTICAL APPROACH: Potential factors associated with advanced colorectal neoplasia were explored using multivariable logistic regression. Sensitivity analyses were performed using grouped LASSO (least absolute shrinkage and selection operator) logistic regression. RESULTS: Among 1,706 patients who received FIT-based screening-791 with CKD stages 3-5 not receiving kidney replacement therapy (KRT), 418 receiving dialysis, and 497 patients with a functioning kidney transplant-117 patients (6.9%) were detected to have advanced colorectal neoplasia (54 with CKD stages 3-5 without KRT, 34 receiving dialysis, and 29 transplant recipients), including 9 colorectal cancers. The factors found to be associated with advanced colorectal neoplasia included older age (OR per year older, 1.05 [95% CI, 1.03-1.07], P<0.001), male sex (OR, 2.27 [95% CI, 1.45-3.54], P<0.001), azathioprine use (OR, 2.99 [95% CI, 1.40-6.37], P=0.005), and erythropoiesis-stimulating agent use (OR, 1.92 [95% CI, 1.22-3.03], P=0.005). Grouped LASSO logistic regression revealed similar associations between these factors and advanced colorectal neoplasia. LIMITATIONS: Unmeasured confounding factors. CONCLUSIONS: Older age, male sex, erythropoiesis-stimulating agents, and azathioprine were found to be significantly associated with advanced colorectal neoplasia in patients with CKD.
引用
- Au EH, Wong G, Howard K, et al. Factors Associated With Advanced Colorectal Neoplasia in Patients With CKD. Am J Kidney Dis. 2021. PMID: 34461168. doi:10.1053/j.ajkd.2021.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。